EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access

Quantitative evaluation of 90 Y‐PET/CT and 90 Y‐SPECT/CT‐based dosimetry following Yttrium‐90 radioembolization

Srinivas Cheenu Kappadath, Eric Courtney Henry, Benjamin P Lopez, Armeen Mahvash

Medical Physics · 2024-09 · 51 (9) · 6061-6074

DOI: 10.1002/mp.17175 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Medical Physics, online erschienen am 23.05.2024. Verfasst von Srinivas Cheenu Kappadath und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Yttrium Radioisotopes, Positron Emission Tomography Computed Tomography, Embolization, Therapeutic, Radiometry. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, University of Texas MD Anderson Cancer Center, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Following yttrium‐90 radioembolization ( 90 Y‐RE), 90 Y‐PET/CT and 90 Y‐SPECT/CT imaging provide the means to calculate the voxelized absorbed dose distribution. Given the widespread use of the two imaging modalities and lack of well‐established standardized dosimetry protocols for 90 Y‐RE, there is a clinical need to systematically investigate and evaluate differences in the performance of voxel‐based dosimetry between 90 Y‐PET/CT and 90 Y‐SPECT/CT.

Purpose

To quantitatively analyze and compare 90 Y‐PET/CT and 90 Y‐SPECT/CT‐based dosimetry following 90 Y‐RE.

Methods

90 Y‐PET/CT and 90 Y‐SPECT/CT imaging was acquired for 35 patients following 90 Y‐RE with TheraSphere for the treatment of unresectable hepatocellular carcinoma. Dosimetry was performed using the local deposition method with known activity and the mean dose ( D mean ) was calculated for perfused liver volumes (PV), tumors (T), and perfused normal livers (NL). Additionally, the absorbed dose to x% of the volume ( D x , x [5%, 10%, …, 90%, 95%]) and the volume receiving y Gy ( V y , y [10 Gy, 20 Gy, …, 190 Gy, 200 Gy]) were calculated for T and NL, respectively. Dose metrics were compared using linear regression, Bland‐Altman analysis, and statistical testing.

Results

Both 90 Y‐SPECT/CT and 90 Y‐PET/CT‐based tumor D mean were strongly correlated ( R 2 ≥ 0.90) with D x , excluding metrics on the extrema. Intra‐modality comparisons of various D x and V y metrics yielded statistically significant differences (ANOVA, p < 0.001) for both 90 Y‐PET/CT and 90 Y‐SPECT/CT. Based on statistical testing, only D x metrics separated by greater than 20%–30% coverage, and only V y metrics separated by greater than 40–70 Gy, reported significant differences. For PV, there was a strong correlation ( R 2 ≥ 0.99) between D mean derived separately from 90 Y‐PET/CT and 90 Y‐SPECT/CT imaging. The strength of the correlation was slightly reduced for T and NL with R 2 = 0.91 and R 2 = 0.95, respectively. For PV, the mean bias ± standard error (SE) and 95% limits of agreement (LOA) between D mean from the two modalities was effectively zero with ‐0.8 ± 0.4% (± 2.5%). For T and NL, the mean bias ± SE (± LOA) was ‐14.5 ± 3.7% (± 24%) and 9.4 ± 4.7% (± 27%), respectively.

Conclusion

The strong correlation between D mean and D x suggests information from multiple dose metrics (e.g., D 70 and D mean ) is largely redundant when establishing dose‐response relationships in 90 Y‐RE. D mean is highly correlated between 90 Y‐PET/CT and 90 Y‐SPECT/CT‐based dosimetry, for all liver VOIs. Relative to 90 Y‐SPECT/CT, 90 Y‐PET/CT, on average, yielded higher D mean to tumors (14%) and lower D mean to perfused normal livers (9%). Absorbed dose differences for perfused liver volumes between 90 Y‐SPECT/CT and 90 Y‐PET/CT were negligible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Yttrium RadioisotopesPositron Emission Tomography Computed TomographyEmbolization, TherapeuticRadiometryLiver NeoplasmsHumansMaleFemaleCarcinoma, HepatocellularMiddle AgedAgedSingle Photon Emission Computed Tomography Computed Tomography

Stichwörter der Autor:innen

PETSIRTSPECTdosimetryradioembolizationyttrium‐90

Substanzen

Yttrium RadioisotopesYttrium-90

Autor:innen und Institutionen

  • Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Förderung

  • NCI NIH HHS
  • University of Texas MD Anderson Cancer Center
  • NIH HHS
  • Boston Scientific
  • Boston Scientific Corporation
  • National Institutes of Health

Zitieren

APA

Kappadath, S. C., Henry, E. C., Lopez, B. P., & Mahvash, A. (2024). Quantitative evaluation of 90 Y‐PET/CT and 90 Y‐SPECT/CT‐based dosimetry following Yttrium‐90 radioembolization. Medical Physics, 51(9), 6061-6074. https://doi.org/10.1002/mp.17175

Vancouver

Kappadath SC, Henry EC, Lopez BP, Mahvash A. Quantitative evaluation of 90 Y‐PET/CT and 90 Y‐SPECT/CT‐based dosimetry following Yttrium‐90 radioembolization. Medical Physics. 2024;51(9):6061-6074. doi:10.1002/mp.17175

BibTeX
@article{Kappadath2024,
  author = {Kappadath, Srinivas Cheenu and Henry, Eric Courtney and Lopez, Benjamin P and Mahvash, Armeen},
  title = {Quantitative evaluation of 90 Y‐PET/CT and 90 Y‐SPECT/CT‐based dosimetry following Yttrium‐90 radioembolization},
  journal = {Medical Physics},
  year = {2024},
  volume = {51},
  number = {9},
  pages = {6061--6074},
  doi = {10.1002/mp.17175}
}
Kostenlos starten →